ChristianaCare

All visitors are required to wear masks.

For COVID-19 safety, all visitors to ChristianaCare facilities and services are required to wear masks. This includes visitors who are vaccinated. Please read our visitor guidelines before arrival.

Masks required at outpatient locations; visitors and support persons limited

All visitors at outpatient locations must be masked in alignment with the masking guidelines on our visitation policy page here. Patients at ChristianaCare’s outpatient services are advised to come to their appointments alone unless a support person is absolutely needed. If a support person is needed, such as a parent, guardian or spokesperson, we highly encourage that the support person be vaccinated. Outpatient practices are not requiring vaccination or a negative COVID test for visitors at this time.

All hospital visitors required to be vaccinated or have a negative COVID-19 test.

  • Inpatients in our Christiana, Wilmington and Union hospitals may have one visitor daily between 10 a.m. and 8 p.m. The visitor must be 16 or older.
  • Patients having outpatient surgery may have one support person accompany them. Support persons must be 16 or older.
  • All visitors and surgical support people must show proof of vaccination OR a negative COVID-19 test within the prior 72 hours.

Before visiting, click here for more details about visitation.

Visit coronavirus.delaware.gov or cecilcountyhealth.org for local vaccination and testing sites.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

About Cancer Clinical Trials

When you join a cancer research study, commonly referred to as a clinical trial, you benefit from some of the latest techniques and therapeutic advances in the fight against cancer. At the same time, you are helping to improve our knowledge in ways that will help people with cancer to live longer and enjoy a better quality of life. Other benefits of clinical trials include:

  • The very latest medicines available to treat your cancer.
  • Frequent and thorough medical exams.
  • The latest information to help you better understand your condition.
  • The guidance you need to improve your health.
  • Support and counseling from doctors and nurses on the hospital’s research staff.

There are four types of cancer clinical trials:

  • Prevention trials test new drugs or techniques designed to prevent the development of cancer in people at risk.
  • Control trials test treatments for the symptoms and side effects caused by cancer and examine quality-of-life issues.
  • CCDR trials are focused on patient, provider and organizational level influences on cancer outcomes.
  • Treatment trials test the effectiveness of new cancer therapies and drugs.

Along with our partners at the Cawley Center for Translational Cancer Research and the University of Delaware Department of Biological Sciences, ChristianaCare’s Cancer Research Program conducts all three types of clinical trials. If you are a patient at the Helen F. Graham Cancer Center & Research Institute, your cancer care-management team will discuss clinical trials with you. But you may also contact the Cancer Research Program directly to learn more about clinical trials and find out which ones you may be eligible for. For immediate, real-time access to all National Cancer Institute approved cancer trials that are open at ChristianaCare, visit Clinicaltrials.gov.

Researching the cancer-fighting drugs of tomorrow

Treatment trials that test new cancer drugs proceed through several stages before successful new drugs can be made available to the general population. These drugs are first tested in laboratory and animal studies. Medicines that proceed to be tested in people must follow rigid guidelines set by the U.S. Food and Drug Administration.

Research studies to test new drugs in people are categorized in four phases:

  • Phase I clinical trials involve a small group of volunteers. They are designed to test a drug’s safety and to determine how it works in the human body.
  • Phase II studies test the effectiveness of the drug on a few hundred, closely monitored volunteer patients who have the disease the drug is designed to treat.
  • Phase III trials involve several thousand volunteer patients who are closely monitored in clinics and hospitals to confirm the effectiveness and adverse effects of the drug in treating their illness compared to standard therapy.
  • Phase IV trials are sometimes required by the FDA to evaluate any long-term effects of a drug or treatment.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Suite 2200, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.